Gold Miners are having a nice year, but are they helping Paulson & Co.?
John Paulson stays in the news every year, not just because he is rich and famous but also because usually one asset class in his portfolio is significantly underperforming. This year the worst performer so far has been Pharmaceuticals, where stocks have slumped on unfavorable M&A activity and other bad news, but more on that later.
Paulson slashed longs in gold ETF and gold miners
Paulson has been a gold bull for as long as one can remember, and in the first quarter, he again sold part of his stake in the SPDR gold ETF. Paulson & Co. slashed its...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
